Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Why Keep a Seat at the AMA Table?

Kelly Tyrrell  |  January 18, 2017

As 2017 unfolds—a year when MACRA begins, lawmakers take steps to dismantle the health reform efforts of the past eight years, and political uncertainty is the rule—it is imperative that the ACR leverage its advocacy agenda by maintaining its seat at the American Medical Association’s (AMA’s) House of Delegates (HOD), says Gary Bryant, MD, FACP and chair of the ACR’s delegation to the HOD.

AMA: The Largest Voice
“The AMA is the largest physician organization and convener of all physician voices. It leverages the voices of the rheumatology community, on behalf of the specialty and our patients,” says Dr. Bryant. “We wouldn’t be able to do that ourselves given our size. It gives us a seat at the table for making policy.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The HOD is the policy-making arm of the AMA, driven not by politics and ideology, but by the policy priorities represented by its members. The HOD comprises representatives of all 50 states, several U.S. territories and more than 170 specialty societies. The ACR has two delegates to the AMA, including Dr. Bryant.

A Megaphone for the ACR
As the country’s largest and most visible physician society, the AMA provides the ACR, a relatively small subspecialty, a megaphone to amplify our voice at federal and state levels. The HOD meets twice a year, and each year, the ACR’s delegates bring at least one or two resolutions to the table. Resolutions have the potential to become official policy of the AMA or directives that determine where the AMA focuses its efforts.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In recent years, the ACR has, through the AMA HOD (and in concert with RheumPAC and the ACR’s Government Affairs Committee), helped achieve several high-priority goals, such as:

  • Exempting small rheumatology practices from some parts of MACRA;
  • Protecting individualized compounding in physicians’ offices from the FDA’s definition of a compounding facility; and
  • Blocking the Medicare Part B Demonstration Project.

Not Your Grandfather’s AMA
In order to keep our seat at the HOD table and participate in other vital activities of the AMA—including the Relative Update Committee (RUC) and the CPT Advisory Committee—at least 1,000 ACR members must also be members of the AMA.

 This year, the AMA will conduct its five-year review of the ACR’s membership. Thus, ACR members should renew their membership in or join the AMA, Dr. Bryant says. He recognizes ACR members may have mixed feelings about the AMA or have had negative experiences with the organization in the past; however, “this is not your grandfather’s AMA,” he says. “In my 15 years [as part of the ACR AMA delegation], I have seen a significant evolution of those elected to AMA offices and who is sitting on the dais at the AMA HOD meetings.”

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice SupportProfessional Topics Tagged with:AMA House of Delegates (HOD)American Medical Association (AMA)RheumPAC

Related Articles

    The ACR’s Representation in American Medical Association Critical as Review Looms

    March 17, 2017

    There is a saying that if the American Medical Association (AMA) did not exist, we would have to invent it. That is just what Dr. Nathan S. Davis did back in 1845 when he called for a national medical convention and laid the foundation for the establishment of the AMA in 1847. This new group would…

    Revisionist History: Seat Belts & Resistance to Public Health Measures

    October 13, 2021

    Some were furious. State by state, laws were enacted to ensure compliance. In most states, the laws were accompanied by a modest fine, as an added incentive. By the time the laws were written, most understood they were based on good science and common sense. The potential to save lives and prevent tragedy was finally…

    Pointers for Rheumatologists Considering AMA Membership

    February 3, 2012

    Join the AMA. Don’t join because you agree with everything the AMA does. Join so we, as rheumatologists, will continue to have a voice and make a difference.

    Keep ACR’s Advocacy Voice Strong with the American Medical Association

    July 6, 2022

    As the result of years of coalition work with partners at the AMA, the ACR recently celebrated a major advocacy win when the FTC announced an investigation of PBM business practices. Join or renew your AMA membership before Sept. 1 so the ACR can keep delegate seats to drive action within the AMA.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences